Highlights
- CES Innovative Pharmaceuticals Index (CESIBT) up 9.2 per cent following the inclusion of innovative drugs in the Drug Catalog for Medical Insurance
- Thanks to increasing demands for Mainland manufactured chips and semiconductor parts, relevant companies showed outstanding performance. CES China Semiconductor Index (CESCSC) soared 7.7 per cent
- Net capital inflow to the Mainland China reached RMB13.2 billion in August. CES Foreign A-Shares Choice Index (CESFAC) edged up 2.6 per cent
- Announcement by the MSCI to raise the inclusion factor of A shares in its indexes from 10 per cent to 15 per cent
- Record low RMB exchange rate in 11.5 years as a result of Sino-US trade tension
- Further recognition of Shenzhen as a Pioneering Demonstration Zone fosters financial cooperation between Shenzhen and Hong Kong
Click here for full details.
